According to YH Research, the global market for PSD95 Monoclonal Antibody should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China PSD95 Monoclonal Antibody market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States PSD95 Monoclonal Antibody market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Recombinant segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Flow Cytometry has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of PSD95 Monoclonal Antibody include Sino Biological, Inc., Cell Signaling Technology, Inc., Bio-Techne, OriGene Technologies, Inc., LifeSpan BioSciences, Inc, Abbexa, MyBiosource, Inc., Biorbyt and Creative Biolabs, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
PSD95 Monoclonal Antibody is an unconjugated antibody to PSD95.
This report aims to provide a comprehensive study of the global market for PSD95 Monoclonal Antibody. Report Highlights:
(1) Global PSD95 Monoclonal Antibody market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global PSD95 Monoclonal Antibody market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China PSD95 Monoclonal Antibody market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global PSD95 Monoclonal Antibody segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global PSD95 Monoclonal Antibody segment by type and by application and regional segment by type and by application.
(6) Global major production regions of PSD95 Monoclonal Antibody, capacity, production and trends.
(7) PSD95 Monoclonal Antibody industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Recombinant
Non-recombinant
Market segment by application, can be divided into
Flow Cytometry
ELISA
Western Blot
Immunoprecipitation
Immunofluorescence
Other
Market segment by players, this report covers
Sino Biological, Inc.
Cell Signaling Technology, Inc.
Bio-Techne
OriGene Technologies, Inc.
LifeSpan BioSciences, Inc
Abbexa
MyBiosource, Inc.
Biorbyt
Creative Biolabs
Assay Genie
RayBiotech, Inc.
1 Market Overview
1.1 PSD95 Monoclonal Antibody Definition
1.2 Global PSD95 Monoclonal Antibody Market Size and Forecast
1.2.1 By Revenue, Global PSD95 Monoclonal Antibody Market Size, 2018-2029
1.2.2 By Sales Volume, Global PSD95 Monoclonal Antibody Market Size, 2018-2029
1.2.3 Global PSD95 Monoclonal Antibody Price Trend, 2018-2029
1.3 China PSD95 Monoclonal Antibody Market Size and Forecast
1.3.1 By Revenue, China PSD95 Monoclonal Antibody Market Size, 2018-2029
1.3.2 By Sales Volume, China PSD95 Monoclonal Antibody Market Size, 2018-2029
1.3.3 China PSD95 Monoclonal Antibody Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China PSD95 Monoclonal Antibody Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China PSD95 Monoclonal Antibody Share in Global Market, 2018-2029
1.4.3 PSD95 Monoclonal Antibody Market Size: China VS Global, 2018-2029
1.5 PSD95 Monoclonal Antibody Market Dynamics
1.5.1 PSD95 Monoclonal Antibody Market Drivers
1.5.2 PSD95 Monoclonal Antibody Market Restraints
1.5.3 PSD95 Monoclonal Antibody Industry Trends
1.5.4 PSD95 Monoclonal Antibody Industry Policy
2 Global Competitive Landscape by Company
2.1 Global PSD95 Monoclonal Antibody Revenue by Company, 2018-2023
2.2 Global PSD95 Monoclonal Antibody Sales Volume by Company, 2018-2023
2.3 Global PSD95 Monoclonal Antibody Price by Company, 2018-2023
2.4 Global PSD95 Monoclonal Antibody Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global PSD95 Monoclonal Antibody Concentration Ratio
2.6 Global PSD95 Monoclonal Antibody Mergers & Acquisitions, Expansion Plans
2.7 Global PSD95 Monoclonal Antibody Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China PSD95 Monoclonal Antibody Revenue by Company, 2018-2023
3.2 China PSD95 Monoclonal Antibody Sales Volume by Company, 2018-2023
3.3 China PSD95 Monoclonal Antibody PSD95 Monoclonal Antibody Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China PSD95 Monoclonal Antibody Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, PSD95 Monoclonal Antibody Domestic VS Export
3.6 China Market, PSD95 Monoclonal Antibody Import & Export
3.6.1 China Market, PSD95 Monoclonal Antibody Import & Export, 2018-2029
3.6.2 China PSD95 Monoclonal Antibody Import & Export Trends
3.6.3 Main Sources of China PSD95 Monoclonal Antibody Import
3.6.4 Export Destination of China PSD95 Monoclonal Antibody
4 PSD95 Monoclonal Antibody Production by Region
4.1 Global PSD95 Monoclonal Antibody Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of PSD95 Monoclonal Antibody Manufacturers
4.3 Global Major Manufacturers, PSD95 Monoclonal Antibody Capacity Expansion and Future Plans
4.4 Global PSD95 Monoclonal Antibody Capacity by Region
4.5 Global PSD95 Monoclonal Antibody Production by Region
4.5.1 Global PSD95 Monoclonal Antibody Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global PSD95 Monoclonal Antibody Production by Region, 2018-2023
4.5.3 Global PSD95 Monoclonal Antibody Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 PSD95 Monoclonal Antibody Industry Chain
5.2 PSD95 Monoclonal Antibody Upstream Analysis
5.2.1 PSD95 Monoclonal Antibody Core Raw Materials
5.2.2 Main Manufacturers of PSD95 Monoclonal Antibody Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 PSD95 Monoclonal Antibody Production Mode
5.6 PSD95 Monoclonal Antibody Procurement Model
5.7 PSD95 Monoclonal Antibody Industry Sales Model and Sales Channels
5.7.1 PSD95 Monoclonal Antibody Sales Model
5.7.2 PSD95 Monoclonal Antibody Typical Distributors
6 Sights by Type
6.1 PSD95 Monoclonal Antibody Classification
6.1.1 Recombinant
6.1.2 Non-recombinant
6.2 By Type, Global PSD95 Monoclonal Antibody Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global PSD95 Monoclonal Antibody Revenue, 2018-2029
6.4 By Type, Global PSD95 Monoclonal Antibody Sales Volume, 2018-2029
6.5 By Type, Global PSD95 Monoclonal Antibody Price, 2018-2029
7 Sights by Application
7.1 PSD95 Monoclonal Antibody Segment by Application
7.1.1 Flow Cytometry
7.1.2 ELISA
7.1.3 Western Blot
7.1.4 Immunoprecipitation
7.1.5 Immunofluorescence
7.1.6 Other
7.2 By Application, Global PSD95 Monoclonal Antibody Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global PSD95 Monoclonal Antibody Revenue, 2018-2029
7.4 By Application, Global PSD95 Monoclonal Antibody Sales Volume, 2018-2029
7.5 By Application, Global PSD95 Monoclonal Antibody Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global PSD95 Monoclonal Antibody Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global PSD95 Monoclonal Antibody Revenue, 2018-2029
8.3 By Region, Global PSD95 Monoclonal Antibody Sales Volume, 2018-2029
8.4 North America
8.4.1 North America PSD95 Monoclonal Antibody Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America PSD95 Monoclonal Antibody Market Size Market Share
8.5 Europe
8.5.1 Europe PSD95 Monoclonal Antibody Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe PSD95 Monoclonal Antibody Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific PSD95 Monoclonal Antibody Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific PSD95 Monoclonal Antibody Market Size Market Share
8.7 South America
8.7.1 South America PSD95 Monoclonal Antibody Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America PSD95 Monoclonal Antibody Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global PSD95 Monoclonal Antibody Market Size & CAGR,2018 VS 2022 VS 2029
9.2 By Country, Global PSD95 Monoclonal Antibody Revenue, 2018-2029
9.3 By Country, Global PSD95 Monoclonal Antibody Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. PSD95 Monoclonal Antibody Market Size, 2018-2029
9.4.2 By Company, U.S. PSD95 Monoclonal Antibody Sales Volume Market Share, 2022
9.4.3 By Type, U.S. PSD95 Monoclonal Antibody Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. PSD95 Monoclonal Antibody Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe PSD95 Monoclonal Antibody Market Size, 2018-2029
9.5.2 By Company, Europe PSD95 Monoclonal Antibody Sales Volume Market Share, 2022
9.5.3 By Type, Europe PSD95 Monoclonal Antibody Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe PSD95 Monoclonal Antibody Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China PSD95 Monoclonal Antibody Market Size, 2018-2029
9.6.2 By Company, China PSD95 Monoclonal Antibody Sales Volume Market Share, 2022
9.6.3 By Type, China PSD95 Monoclonal Antibody Market Size, Share, 2022 VS 2029
9.6.4 By Application, China PSD95 Monoclonal Antibody Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan PSD95 Monoclonal Antibody Market Size, 2018-2029
9.7.2 By Company, Japan PSD95 Monoclonal Antibody Sales Volume Market Share, 2022
9.7.3 By Type, Japan PSD95 Monoclonal Antibody Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan PSD95 Monoclonal Antibody Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea PSD95 Monoclonal Antibody Market Size, 2018-2029
9.8.2 By Company, South Korea PSD95 Monoclonal Antibody Sales Volume Market Share, 2022
9.8.3 By Type, South Korea PSD95 Monoclonal Antibody Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea PSD95 Monoclonal Antibody Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia PSD95 Monoclonal Antibody Market Size, 2018-2029
9.9.2 By Company, Southeast Asia PSD95 Monoclonal Antibody Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia PSD95 Monoclonal Antibody Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia PSD95 Monoclonal Antibody Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India PSD95 Monoclonal Antibody Market Size, 2018-2029
9.10.2 By Company, India PSD95 Monoclonal Antibody Sales Volume Market Share, 2022
9.10.3 By Type, India PSD95 Monoclonal Antibody Market Size, Share, 2022 VS 2029
9.10.4 By Application, India PSD95 Monoclonal Antibody Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia PSD95 Monoclonal Antibody Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia PSD95 Monoclonal Antibody Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia PSD95 Monoclonal Antibody Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia PSD95 Monoclonal Antibody Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Sino Biological, Inc.
10.1.1 Sino Biological, Inc. Company Information, Head Office, Market Area and Industry Position
10.1.2 Sino Biological, Inc. PSD95 Monoclonal Antibody Models, Specifications and Application
10.1.3 Sino Biological, Inc. PSD95 Monoclonal Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Sino Biological, Inc. Company Profile and Main Business
10.1.5 Sino Biological, Inc. Recent Developments
10.2 Cell Signaling Technology, Inc.
10.2.1 Cell Signaling Technology, Inc. Company Information, Head Office, Market Area and Industry Position
10.2.2 Cell Signaling Technology, Inc. PSD95 Monoclonal Antibody Models, Specifications and Application
10.2.3 Cell Signaling Technology, Inc. PSD95 Monoclonal Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Cell Signaling Technology, Inc. Company Profile and Main Business
10.2.5 Cell Signaling Technology, Inc. Recent Developments
10.3 Bio-Techne
10.3.1 Bio-Techne Company Information, Head Office, Market Area and Industry Position
10.3.2 Bio-Techne PSD95 Monoclonal Antibody Models, Specifications and Application
10.3.3 Bio-Techne PSD95 Monoclonal Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Bio-Techne Company Profile and Main Business
10.3.5 Bio-Techne Recent Developments
10.4 OriGene Technologies, Inc.
10.4.1 OriGene Technologies, Inc. Company Information, Head Office, Market Area and Industry Position
10.4.2 OriGene Technologies, Inc. PSD95 Monoclonal Antibody Models, Specifications and Application
10.4.3 OriGene Technologies, Inc. PSD95 Monoclonal Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 OriGene Technologies, Inc. Company Profile and Main Business
10.4.5 OriGene Technologies, Inc. Recent Developments
10.5 LifeSpan BioSciences, Inc
10.5.1 LifeSpan BioSciences, Inc Company Information, Head Office, Market Area and Industry Position
10.5.2 LifeSpan BioSciences, Inc PSD95 Monoclonal Antibody Models, Specifications and Application
10.5.3 LifeSpan BioSciences, Inc PSD95 Monoclonal Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 LifeSpan BioSciences, Inc Company Profile and Main Business
10.5.5 LifeSpan BioSciences, Inc Recent Developments
10.6 Abbexa
10.6.1 Abbexa Company Information, Head Office, Market Area and Industry Position
10.6.2 Abbexa PSD95 Monoclonal Antibody Models, Specifications and Application
10.6.3 Abbexa PSD95 Monoclonal Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Abbexa Company Profile and Main Business
10.6.5 Abbexa Recent Developments
10.7 MyBiosource, Inc.
10.7.1 MyBiosource, Inc. Company Information, Head Office, Market Area and Industry Position
10.7.2 MyBiosource, Inc. PSD95 Monoclonal Antibody Models, Specifications and Application
10.7.3 MyBiosource, Inc. PSD95 Monoclonal Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 MyBiosource, Inc. Company Profile and Main Business
10.7.5 MyBiosource, Inc. Recent Developments
10.8 Biorbyt
10.8.1 Biorbyt Company Information, Head Office, Market Area and Industry Position
10.8.2 Biorbyt PSD95 Monoclonal Antibody Models, Specifications and Application
10.8.3 Biorbyt PSD95 Monoclonal Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Biorbyt Company Profile and Main Business
10.8.5 Biorbyt Recent Developments
10.9 Creative Biolabs
10.9.1 Creative Biolabs Company Information, Head Office, Market Area and Industry Position
10.9.2 Creative Biolabs PSD95 Monoclonal Antibody Models, Specifications and Application
10.9.3 Creative Biolabs PSD95 Monoclonal Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Creative Biolabs Company Profile and Main Business
10.9.5 Creative Biolabs Recent Developments
10.10 Assay Genie
10.10.1 Assay Genie Company Information, Head Office, Market Area and Industry Position
10.10.2 Assay Genie PSD95 Monoclonal Antibody Models, Specifications and Application
10.10.3 Assay Genie PSD95 Monoclonal Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Assay Genie Company Profile and Main Business
10.10.5 Assay Genie Recent Developments
10.11 RayBiotech, Inc.
10.11.1 RayBiotech, Inc. Company Information, Head Office, Market Area and Industry Position
10.11.2 RayBiotech, Inc. PSD95 Monoclonal Antibody Models, Specifications and Application
10.11.3 RayBiotech, Inc. PSD95 Monoclonal Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 RayBiotech, Inc. Company Profile and Main Business
10.11.5 RayBiotech, Inc. Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables and Figures
Table 1. PSD95 Monoclonal Antibody Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. PSD95 Monoclonal Antibody Market Restraints
Table 3. PSD95 Monoclonal Antibody Market Trends
Table 4. PSD95 Monoclonal Antibody Industry Policy
Table 5. Global PSD95 Monoclonal Antibody Revenue by Company, 2018-2023, US$ million
Table 6. Global PSD95 Monoclonal Antibody Revenue Market Share by Company, 2018-2023
Table 7. Global PSD95 Monoclonal Antibody Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global PSD95 Monoclonal Antibody Sales Volume Market Share by Company, 2018-2023
Table 9. Global PSD95 Monoclonal Antibody Price by Company, 2018-2023, (US$/Unit)
Table 10. Global PSD95 Monoclonal Antibody Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global PSD95 Monoclonal Antibody Mergers & Acquisitions, Expansion Plans
Table 12. Global PSD95 Monoclonal Antibody Manufacturers Product Type
Table 13. China PSD95 Monoclonal Antibody Revenue by Company, 2018-2023, US$ million
Table 14. China PSD95 Monoclonal Antibody Revenue Market Share by Company, 2018-2023
Table 15. China PSD95 Monoclonal Antibody Sales Volume by Company, 2018-2023, (K Units)
Table 16. China PSD95 Monoclonal Antibody Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, PSD95 Monoclonal Antibody Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China PSD95 Monoclonal Antibody Import & Export Trends
Table 19. Main Sources of China PSD95 Monoclonal Antibody Import
Table 20. Export Destination of China PSD95 Monoclonal Antibody
Table 21. Global Headquarters and Manufacturing Base of PSD95 Monoclonal Antibody Manufacturers
Table 22. Global Major Manufacturers, PSD95 Monoclonal Antibody Capacity Expansion and Future Plans
Table 23. Global PSD95 Monoclonal Antibody Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global PSD95 Monoclonal Antibody Production by Region, 2018-2023, (K Units)
Table 25. Global PSD95 Monoclonal Antibody Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of PSD95 Monoclonal Antibody Upstream (Raw Materials)
Table 27. Global PSD95 Monoclonal Antibody Typical Customers
Table 28. PSD95 Monoclonal Antibody Typical Distributors
Table 29. By Type, Global PSD95 Monoclonal Antibody Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global PSD95 Monoclonal Antibody Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global PSD95 Monoclonal Antibody Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global PSD95 Monoclonal Antibody Revenue, 2018-2029, US$ Million
Table 33. By Region, Global PSD95 Monoclonal Antibody Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global PSD95 Monoclonal Antibody Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global PSD95 Monoclonal Antibody Revenue, 2018-2029, US$ Million
Table 36. By Country, Global PSD95 Monoclonal Antibody Revenue Market Share, 2018-2029
Table 37. By Country, Global PSD95 Monoclonal Antibody Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global PSD95 Monoclonal Antibody Sales Volume Market Share, 2018-2029
Table 39. Sino Biological, Inc. Company Information, Head Office, Market Area and Industry Position
Table 40. Sino Biological, Inc. PSD95 Monoclonal Antibody Models, Specifications and Application
Table 41. Sino Biological, Inc. PSD95 Monoclonal Antibody Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Sino Biological, Inc. Company Profile and Main Business
Table 43. Sino Biological, Inc. Recent Developments
Table 44. Cell Signaling Technology, Inc. Company Information, Head Office, Market Area and Industry Position
Table 45. Cell Signaling Technology, Inc. PSD95 Monoclonal Antibody Models, Specifications and Application
Table 46. Cell Signaling Technology, Inc. PSD95 Monoclonal Antibody Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Cell Signaling Technology, Inc. Company Profile and Main Business
Table 48. Cell Signaling Technology, Inc. Recent Developments
Table 49. Bio-Techne Company Information, Head Office, Market Area and Industry Position
Table 50. Bio-Techne PSD95 Monoclonal Antibody Models, Specifications and Application
Table 51. Bio-Techne PSD95 Monoclonal Antibody Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Bio-Techne Company Profile and Main Business
Table 53. Bio-Techne Recent Developments
Table 54. OriGene Technologies, Inc. Company Information, Head Office, Market Area and Industry Position
Table 55. OriGene Technologies, Inc. PSD95 Monoclonal Antibody Models, Specifications and Application
Table 56. OriGene Technologies, Inc. PSD95 Monoclonal Antibody Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. OriGene Technologies, Inc. Company Profile and Main Business
Table 58. OriGene Technologies, Inc. Recent Developments
Table 59. LifeSpan BioSciences, Inc Company Information, Head Office, Market Area and Industry Position
Table 60. LifeSpan BioSciences, Inc PSD95 Monoclonal Antibody Models, Specifications and Application
Table 61. LifeSpan BioSciences, Inc PSD95 Monoclonal Antibody Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. LifeSpan BioSciences, Inc Company Profile and Main Business
Table 63. LifeSpan BioSciences, Inc Recent Developments
Table 64. Abbexa Company Information, Head Office, Market Area and Industry Position
Table 65. Abbexa PSD95 Monoclonal Antibody Models, Specifications and Application
Table 66. Abbexa PSD95 Monoclonal Antibody Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Abbexa Company Profile and Main Business
Table 68. Abbexa Recent Developments
Table 69. MyBiosource, Inc. Company Information, Head Office, Market Area and Industry Position
Table 70. MyBiosource, Inc. PSD95 Monoclonal Antibody Models, Specifications and Application
Table 71. MyBiosource, Inc. PSD95 Monoclonal Antibody Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. MyBiosource, Inc. Company Profile and Main Business
Table 73. MyBiosource, Inc. Recent Developments
Table 74. Biorbyt Company Information, Head Office, Market Area and Industry Position
Table 75. Biorbyt PSD95 Monoclonal Antibody Models, Specifications and Application
Table 76. Biorbyt PSD95 Monoclonal Antibody Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Biorbyt Company Profile and Main Business
Table 78. Biorbyt Recent Developments
Table 79. Creative Biolabs Company Information, Head Office, Market Area and Industry Position
Table 80. Creative Biolabs PSD95 Monoclonal Antibody Models, Specifications and Application
Table 81. Creative Biolabs PSD95 Monoclonal Antibody Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Creative Biolabs Company Profile and Main Business
Table 83. Creative Biolabs Recent Developments
Table 84. Assay Genie Company Information, Head Office, Market Area and Industry Position
Table 85. Assay Genie PSD95 Monoclonal Antibody Models, Specifications and Application
Table 86. Assay Genie PSD95 Monoclonal Antibody Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Assay Genie Company Profile and Main Business
Table 88. Assay Genie Recent Developments
Table 89. RayBiotech, Inc. Company Information, Head Office, Market Area and Industry Position
Table 90. RayBiotech, Inc. PSD95 Monoclonal Antibody Models, Specifications and Application
Table 91. RayBiotech, Inc. PSD95 Monoclonal Antibody Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. RayBiotech, Inc. Company Profile and Main Business
Table 93. RayBiotech, Inc. Recent Developments
List of Figure
Figure 1. PSD95 Monoclonal Antibody Picture
Figure 2. By Revenue, Global PSD95 Monoclonal Antibody Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global PSD95 Monoclonal Antibody Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global PSD95 Monoclonal Antibody Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China PSD95 Monoclonal Antibody Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China PSD95 Monoclonal Antibody Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China PSD95 Monoclonal Antibody Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China PSD95 Monoclonal Antibody Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China PSD95 Monoclonal Antibody Share of Global Market, 2018-2029
Figure 10. Global PSD95 Monoclonal Antibody Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global PSD95 Monoclonal Antibody Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China PSD95 Monoclonal Antibody Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China PSD95 Monoclonal Antibody Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China PSD95 Monoclonal Antibody Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of PSD95 Monoclonal Antibody Domestic VS Export, 2022
Figure 16. Global PSD95 Monoclonal Antibody Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global PSD95 Monoclonal Antibody Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global PSD95 Monoclonal Antibody Production Market Share & Forecast by Region, 2018-2029
Figure 19. PSD95 Monoclonal Antibody Industry Chain
Figure 20. PSD95 Monoclonal Antibody Procurement Model
Figure 21. PSD95 Monoclonal Antibody Sales Model
Figure 22. PSD95 Monoclonal Antibody Sales Channels, Direct Sales and Distribution
Figure 23. Recombinant
Figure 24. Non-recombinant
Figure 25. By Type, Global PSD95 Monoclonal Antibody Revenue, 2018-2029, US$ Million
Figure 26. By Type, Global PSD95 Monoclonal Antibody Revenue Market Share, 2018-2029
Figure 27. By Type, Global PSD95 Monoclonal Antibody Sales Volume, 2018-2029, (K Units)
Figure 28. By Type, Global PSD95 Monoclonal Antibody Sales Volume Market Share, 2018-2029
Figure 29. By Type, Global PSD95 Monoclonal Antibody Price, 2018-2029, (US$/Unit)
Figure 30. Flow Cytometry
Figure 31. ELISA
Figure 32. Western Blot
Figure 33. Immunoprecipitation
Figure 34. Immunofluorescence
Figure 35. Other
Figure 36. By Application, Global PSD95 Monoclonal Antibody Revenue, 2018-2029, US$ Million
Figure 37. By Application, Global PSD95 Monoclonal Antibody Revenue Market Share, 2018-2029
Figure 38. By Application, Global PSD95 Monoclonal Antibody Sales Volume, 2018-2029, (K Units)
Figure 39. By Application, Global PSD95 Monoclonal Antibody Sales Volume Market Share, 2018-2029
Figure 40. By Application, Global PSD95 Monoclonal Antibody Price, 2018-2029, (US$/Unit)
Figure 41. By Region, Global PSD95 Monoclonal Antibody Revenue Market Share, 2018-2029
Figure 42. By Region, Global PSD95 Monoclonal Antibody Sales Volume Market Share, 2018-2029
Figure 43. North America PSD95 Monoclonal Antibody Revenue & Forecasts, 2018-2029, US$ Million
Figure 44. By Country, North America PSD95 Monoclonal Antibody Revenue Market Share, 2022
Figure 45. Europe PSD95 Monoclonal Antibody Revenue & Forecasts, 2018-2029, US$ Million
Figure 46. By Country, Europe PSD95 Monoclonal Antibody Revenue Market Share, 2022
Figure 47. Asia Pacific PSD95 Monoclonal Antibody Revenue & Forecasts, 2018-2029, US$ Million
Figure 48. By Country/Region, Asia Pacific PSD95 Monoclonal Antibody Revenue Market Share, 2022
Figure 49. South America PSD95 Monoclonal Antibody Revenue & Forecasts, 2018-2029, US$ Million
Figure 50. By Country, South America PSD95 Monoclonal Antibody Revenue Market Share, 2022
Figure 51. Middle East & Africa PSD95 Monoclonal Antibody Revenue & Forecasts, 2018-2029, US$ Million
Figure 52. U.S. PSD95 Monoclonal Antibody Sales Volume, 2018-2029, (K Units)
Figure 53. By Company, U.S. PSD95 Monoclonal Antibody Market Share, 2022
Figure 54. By Type, U.S. PSD95 Monoclonal Antibody Sales Volume Market Share, 2022 VS 2029
Figure 55. By Application, U.S. PSD95 Monoclonal Antibody Sales Volume Market Share, 2022 VS 2029
Figure 56. Europe PSD95 Monoclonal Antibody Sales Volume, 2018-2029, (K Units)
Figure 57. By Company, Europe PSD95 Monoclonal Antibody Market Share, 2022
Figure 58. By Type, Europe PSD95 Monoclonal Antibody Sales Volume Market Share, 2022 VS 2029
Figure 59. By Application, Europe PSD95 Monoclonal Antibody Sales Volume Market Share, 2022 VS 2029
Figure 60. China PSD95 Monoclonal Antibody Sales Volume, 2018-2029, (K Units)
Figure 61. By Company, China PSD95 Monoclonal Antibody Market Share, 2022
Figure 62. By Type, China PSD95 Monoclonal Antibody Sales Volume Market Share, 2022 VS 2029
Figure 63. By Application, China PSD95 Monoclonal Antibody Sales Volume Market Share, 2022 VS 2029
Figure 64. Japan PSD95 Monoclonal Antibody Sales Volume, 2018-2029, (K Units)
Figure 65. By Company, Japan PSD95 Monoclonal Antibody Market Share, 2022
Figure 66. By Type, Japan PSD95 Monoclonal Antibody Sales Volume Market Share, 2022 VS 2029
Figure 67. By Application, Japan PSD95 Monoclonal Antibody Sales Volume Market Share, 2022 VS 2029
Figure 68. South Korea PSD95 Monoclonal Antibody Sales Volume, 2018-2029, (K Units)
Figure 69. By Company, South Korea PSD95 Monoclonal Antibody Market Share, 2022
Figure 70. By Type, South Korea PSD95 Monoclonal Antibody Sales Volume Market Share, 2022 VS 2029
Figure 71. By Application, South Korea PSD95 Monoclonal Antibody Sales Volume Market Share, 2022 VS 2029
Figure 72. Southeast Asia PSD95 Monoclonal Antibody Sales Volume, 2018-2029, (K Units)
Figure 73. By Company, Southeast Asia PSD95 Monoclonal Antibody Market Share, 2022
Figure 74. By Type, Southeast Asia PSD95 Monoclonal Antibody Sales Volume Market Share, 2022 VS 2029
Figure 75. By Application, Southeast Asia PSD95 Monoclonal Antibody Sales Volume Market Share, 2022 VS 2029
Figure 76. India PSD95 Monoclonal Antibody Sales Volume, 2018-2029, (K Units)
Figure 77. By Company, India PSD95 Monoclonal Antibody Market Share, 2022
Figure 78. By Type, India PSD95 Monoclonal Antibody Sales Volume Market Share, 2022 VS 2029
Figure 79. By Application, India PSD95 Monoclonal Antibody Sales Volume Market Share, 2022 VS 2029
Figure 80. Middle East & Asia PSD95 Monoclonal Antibody Sales Volume, 2018-2029, (K Units)
Figure 81. By Company, Middle East & Asia PSD95 Monoclonal Antibody Market Share, 2022
Figure 82. By Type, Middle East & Asia PSD95 Monoclonal Antibody Sales Volume Market Share, 2022 VS 2029
Figure 83. By Application, Middle East & Asia PSD95 Monoclonal Antibody Sales Volume Market Share, 2022 VS 2029
Figure 84. Research Methodology
Figure 85. Breakdown of Primary Interviews
Figure 86. Bottom-up Approaches
Figure 87. Top-down Approaches
Reason to Buy